When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Exome sequencing - Wikipedia

   en.wikipedia.org/wiki/Exome_sequencing

   Exome sequencing workflow: part 1. Exome sequencing, also known as whole exome sequencing (WES), is a genomic technique for sequencing all of the protein-coding regions of genes in a genome (known as the exome). [1] It consists of two steps: the first step is to select only the subset of DNA that encodes proteins.

3. $1,000 genome - Wikipedia

   en.wikipedia.org/wiki/$1,000_genome

   As the costs of sequencing continued to plummet, in 2008, Illumina announced that it had sequenced an individual genome for $100,000 in reagent costs. Applied Biosystems countered by saying the cost on its platform was $60,000. [17] Pacific Biosciences became the latest entrant in what The New York Times called "a heated race for the '$1,000 ...

4. Veritas Genetics - Wikipedia

   en.wikipedia.org/wiki/Veritas_Genetics

   Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts. [1] According to the company's press release, it was among the first companies to offer whole genome sequencing and interpretation for under $1,000.

5. Personal genomics - Wikipedia

   en.wikipedia.org/wiki/Personal_genomics

   Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips (typically 0.02% of the genome), or partial or full genome sequencing.

6. 1000 Genomes Project - Wikipedia

   en.wikipedia.org/wiki/1000_Genomes_Project

   The third pilot study involves sequencing the coding regions of 1,000 genes in 1,000 people with deep coverage (20×). [14] [15] It was estimated that the project would likely cost more than $500 million if standard DNA sequencing technologies were used.

7. Exome - Wikipedia

   en.wikipedia.org/wiki/Exome

   Whole-exome sequencing is a recent technology that has led to the discovery of various genetic disorders and increased the rate of diagnoses of patients with rare genetic disorders. Overall, whole-exome sequencing has allowed healthcare providers to diagnose 30–50% of patients who were thought to have rare Mendelian disorders.